US Stem Cell Inc (USRM)

[wallas2g1]

You're spot on. Reactivation is a required first step to approval. That is not to say that approval is guaranteed but just putting things in perspective. Today's pr was just an update and nothing else.

I was concerned that USRM didn't have enough data points with 26 patients on the trial but after reading what other companies had it seems it's not so much about the number of patients as it is about the clinical improvement in the condition. I think the odds of approval are more than 50% here.